Vycor Medical Inc
VYCO· OTC
Released May 14, 2021
10-Q filed May 14, 2021, 44 days after period end · 0001493152-21-011418
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Revenue | $295.75K | $330.24K | $350.67K | $325.10K |
| Net Income | -$242.92K | -$174.95K | -$180.30K | -$326.64K |
| EPS Diluted | -$0.01 |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| -$0.01 |
| -$0.01 |
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.